Journal of Molecular Medicine

, Volume 97, Issue 1, pp 1–17 | Cite as

ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits

  • Tom HearnEmail author
Open Access


Alström syndrome (AS) is characterised by metabolic deficits, retinal dystrophy, sensorineural hearing loss, dilated cardiomyopathy and multi-organ fibrosis. Elucidating the function of the mutated gene, ALMS1, is critical for the development of specific treatments and may uncover pathways relevant to a range of other disorders including common forms of obesity and type 2 diabetes. Interest in ALMS1 is heightened by the recent discovery of its involvement in neonatal cardiomyocyte cell cycle arrest, a process with potential relevance to regenerative medicine. ALMS1 encodes a ~ 0.5 megadalton protein that localises to the base of centrioles. Some studies have suggested a role for this protein in maintaining centriole-nucleated sensory organelles termed primary cilia, and AS is now considered to belong to the growing class of human genetic disorders linked to ciliary dysfunction (ciliopathies). However, mechanistic details are lacking, and recent studies have implicated ALMS1 in several processes including endosomal trafficking, actin organisation, maintenance of centrosome cohesion and transcription. In line with a more complex picture, multiple isoforms of the protein likely exist and non-centrosomal sites of localisation have been reported. This review outlines the evidence for both ciliary and extra-ciliary functions of ALMS1.


Actinin ALMS motif Bardet-Biedl syndrome C10orf90 CART complex Centriole Centrosome CEP250 CEP295 C-Nap1 Cilia Ciliopathy Diabetes Endosomal recycling Fibrosis GLUT4 Insulin resistance KIAA1731 Mitogenic cardiomyopathy Notch Obesity Pericentrin RFX Rootlet 


Alström syndrome (AS) is a rare, recessively inherited disorder that affects numerous organ systems [1, 2]. Cardinal features include childhood obesity, insulin resistance, cone-rod retinal dystrophy and sensorineural hearing loss (SNHL). Type 2 diabetes mellitus and hypertriglyceridemia typically develop in childhood or adolescence [2, 3, 4]. Dilated cardiomyopathy (DCM) may arise in infancy, then often resolve or at least abate within 3 years. However, it may recur, or manifest for the first time, in adolescence or adulthood [2, 3, 4, 7]. Other common features include hepatic, renal and pulmonary dysfunction, chronic otitis media in childhood, abnormal spinal curvature (scoliosis, kyphosis or lordosis) arising in adolescence, short stature in adulthood, gastrointestinal disturbances and neurological disturbances such as absence seizures [3, 4, 5, 6]. Fibrosis of multiple organs is a common finding [4].

Understanding the molecular basis of AS is critical for the development of specific therapies. It may also provide new insights into the molecular pathways that go awry in common forms of conditions such as obesity and diabetes, which represent major public health concerns [8, 9].

The prevalence of AS is estimated at 1–9 cases per million individuals, with approximately 950 reported cases [10]. It is caused by mutations in ALMS1, a widely expressed 23-exon gene located on chromosome 2p13 [11, 12]. Over 200 different AS-causing variants have been identified, of which the vast majority are nonsense or frameshift mutations [13, 14]. Almost half occur in exon 8 [14], commensurate with the large size of this exon (6.1 kb, or 49% of the coding sequence). There is little evidence of genotype-phenotype correlation, suggesting that the phenotype is modified by unknown genetic and/or environmental factors [14].

Intriguingly, biallelic mutations in ALMS1 also cause mitogenic cardiomyopathy, an ultra-rare form of DCM characterised by delayed cell cycle arrest of neonatal cardiomyocytes [15, 16]. This condition is fatal in the first months of life, before other clinical features of AS normally manifest. The few mutations reported so far resemble those commonly found in AS, being located in the three largest exons (exons 8, 10 and 16) and predicted to cause premature termination of translation. Alms1 also appears to be required for timely postnatal cell cycle arrest of cardiomyocytes in mice [15]. Thus, mitogenic cardiomyopathy is most likely an extreme form of the infantile DCM often observed in AS [15, 16]. Mechanisms regulating cardiomyocyte cell cycle arrest are of great interest partly because reversing this process could provide a way to stimulate cardiac regeneration after injury [17].

The ALMS1 protein is a component of the centrosome [18, 19], a microtubule (MT)-nucleating organelle comprising two centrioles (termed mother and daughter) and a dynamic assembly of proteins termed pericentriolar material (PCM). Centrioles are evolutionarily conserved cylindrical structures composed of nine triplet MTs, approximately 500 nm in length [20]. Notably, ALMS1 localises specifically to the base, or proximal end, of these structures [21] (Figs. 1 and 2).
Fig. 1

ALMS1 is a centrosomal protein that localises specifically to the proximal end of centrioles/basal bodies. Top (l-r): immunofluorescence microscopy images showing centrosomal staining pattern of ALMS1 in hTERT-RPE1 cells in interphase and mitosis, and in fetal human kidney. The mitotic hTERT-RPE1 cell was co-stained with an antibody to acetylated α-tubulin (Ac-tubulin), which marks centrioles and spindle microtubules. DNA was stained with DAPI (blue). Scale bars, 10 μm. Bottom: ciliated hTERT-RPE1 cell stained with antibodies to ALMS1, the PCM component γ-tubulin and the centriole/axoneme component Ac-tubulin. Localisation of ALMS1 to centriole/basal body proximal ends has been confirmed by super-resolution microscopy [21]. DC daughter centriole, BB basal body. Scale bar, 1 μm

Fig. 2

Primary cilia and the centrosome cycle. In G1 phase of the cell cycle the centrosome contains one mother and one daughter centriole (MC, DC), the MC being distinguished by appendages at its distal end. In S and G2 phases, one procentriole assembles orthogonally to each pre-existing centriole [20]. ALMS1 (green circles) localises to the proximal ends of the MC and DC, from where the centrosome linker extends; it is not known if ALMS1 localises to procentrioles (green question marks). The centrosome linker is dissolved before mitotic entry, facilitating bipolar spindle formation, and reassembles at the end of mitosis when the newly built centriole disengages from its parent’s side. The pre-existing DC acquires appendages in late G2 or M phase and functions as an MC in the following cell cycle [20]. Upon cell cycle exit (G0), most cell types generate a primary cilium. The MC alone is competent to form a cilium, and in this role is termed a basal body (BB). Cilia are typically resorbed upon cell cycle re-entry. However, in some cell types/contexts, they may persist, or re-assemble in interphase, before disassembling prior to mitosis (not shown) [183]. CiPo ciliary pocket, DAP distal appendages, sDAP subdistal appendages

Centrioles duplicate once per cell cycle, beginning at the G1/S transition, and the two resulting centrosomes go on to form the poles of the mitotic spindle [20] (Fig. 2). In interphase, and in some terminally differentiated cell types, the centrosome anchors a radial array of MTs that forms the basis of an intracellular transport system and influences cell shape, polarity and motility [22, 23]. In addition to its classical roles in MT organisation, the centrosome has recently been reported to nucleate actin filaments, facilitate endocytic recycling and direct multiple events at the immunological synapse [24, 25, 26]. It also serves as a hub for components of the cell cycle regulatory machinery and proteasome, and has been linked to the DNA damage response (DDR) [27, 28, 29]. Of note, mutations in genes encoding the centrosomal proteins pericentrin (PCNT) and POC1A are associated with severe insulin resistance [30, 31], while disruption of the centrosomal protein CEP19 causes morbid obesity [32]. Mutations in several centriole biogenesis genes cause forms of microcephaly [20].

Centrioles are vital for the assembly of cilia, hair-like projections that are either motile, as in multiciliated epithelial cells (MCCs), or non-motile. Most quiescent/terminally differentiated (G0) human cells possess a single non-motile (primary) cilium, nucleated by the mother centriole of the centrosome (termed a basal body when ciliated) (Fig. 2). The core, or axoneme, of primary cilia consists of nine doublet MTs and is enclosed in a lipid bilayer that is continuous with the plasma membrane [33]. In many cell types, the periciliary membrane forms an invagination called the ciliary pocket, which is a site of endocytosis and possibly a docking site for Golgi-derived vesicles [34]. Protein synthesis does not occur within cilia and therefore all components must be transported from the cell body. A continuously running MT motor-based system termed intraflagellar transport (IFT) shuttles cargo molecules from the base to the tip of the cilium and vice versa [33]. Importantly, the protein and lipid composition of the ciliary compartment is controlled by a ‘gate’ at the ciliary base, part of which is the transition zone (TZ), defined by Y-shaped links extending from the axoneme to the ciliary membrane [35] (Fig. 2).

Notably, the light-sensing outer segment (OS) of vertebrate photoreceptors is a highly specialised form of primary cilium [36]. The OS is packed with stacks of opsin-containing membrane disks that are shed from the distal end and renewed at the base. This requires high-volume trafficking of OS components from their site of synthesis in the inner segment (IS) through a narrow structure called the connecting cilium (CC), which resembles an extended TZ and is nucleated by a basal body in the distal IS [35, 36]. Another specialised type of primary cilium is present on hair cells in the developing organ of Corti. This ‘kinocilium’ and/or its basal body help to choreograph the formation of mechanically sensitive bundles of stereocilia (actin-based structures unrelated to primary cilia), which are central to hearing, on the apical cell surface [37, 38].

Interest in primary cilia has widened dramatically in recent years due to accumulating evidence of their importance for normal development, tissue homeostasis and energy balance [39, 40, 41]. They appear to sense and process a variety of molecular cues, helping cells throughout the body to respond to changes in the extracellular environment. For example, vertebrate cells require primary cilia to respond to Hedgehog (Hh) family ligands, which play crucial roles in development and stem cell maintenance [42]. The signalling process involves dynamic localisation of effector transcription factors and other pathway components to the ciliary compartment [42]. In growth-arrested cells, platelet-derived growth factor receptor α (PDGFRα) and insulin-like growth factor 1 receptor (IGF-1R) localise to the ciliary membrane, where they trigger downstream signalling upon ligand-binding, leading to responses such as cell cycle re-entry [43, 44, 45]. Primary cilia are involved in numerous other signalling pathways, including the Wnt/PCP (planar cell polarity), Notch and TGF-β pathways, and may thus serve to integrate multiple signals to ensure an appropriate cellular response [39, 46, 47, 48]. The primary cilia of some cells, such as renal tubule epithelial cells, are thought to sense fluid flow via mechanosensitive calcium channel complexes within the ciliary membrane [49]. However, this aspect of cilia function has been questioned by recent data [49, 50].

While cilia-mediated signalling can influence the cell cycle, ciliation status is in turn controlled by cell cycle kinases [51]. Moreover, ciliogenesis and/or cilium length are modulated by inputs from other processes such as autophagy, actin cytoskeleton organisation and ciliary signalling itself [51].

Dozens of genetic disorders have now been linked to cilia dysfunction [52]. Clinical features common to several of these so-called ciliopathies include renal cysts, brain abnormalities, polydactyly and retinal dystrophy [53, 54, 55]. The products of many of the mutated genes have been shown to work together in complexes or functional modules, helping to explain both the genetic heterogeneity of several ciliopathies and the many examples of genetic overlap [52, 53, 54]. ALMS1 loss-of-function has been linked to defects in primary cilium formation, positioning and maintenance, leading to AS being classified as a ciliopathy [56, 57, 58, 59]. However, the precise role of the ALMS1 protein remains uncertain and no clear links have been established with other ciliopathy proteins.

The phenotype of AS resembles that of the genetically heterogeneous ciliopathy Bardet-Biedl syndrome (BBS), which includes childhood obesity, retinal dystrophy, SNHL and susceptibility to type 2 diabetes [9, 60]. The functions of many BBS proteins converge at an evolutionarily conserved protein complex termed the BBSome [61, 62], to which various functions have been ascribed including promotion of ciliary membrane biogenesis, trafficking of ciliary membrane proteins and regulation of IFT particle assembly [61, 63, 64, 65]. BBS proteins also appear to have extraciliary functions, for example mediating trafficking of the insulin and leptin receptors to the plasma membrane [66, 67].

AS also bears similarity to the phenotype of mice with a mutation in the Tub gene, characterised by obesity, insulin resistance, retinal degeneration and SNHL [68, 69]. The Tubby protein is implicated in trafficking G protein-coupled receptors (GPCRs) and transient receptor potential (TRP) channels to neuronal cilia [70, 71], and may also act as a transcription factor [72].

While ALMS1 is known to localise to centrioles/basal bodies [19, 21, 56, 57], localisation to non-centrosomal sites has also been reported and recent studies have implicated the protein in several cellular processes including endosomal trafficking, actin organisation and transcription [73, 74, 75, 76, 77]. On broader scales, ALMS1 has been implicated in neuronal migration, maintenance of cellular quiescence, adipogenesis, spermatogenesis, maintenance of pancreatic β cell mass, adaptive thermogenesis and, as noted above, cell cycle arrest of cardiomyocytes [15, 16, 57, 78, 79, 80, 81, 82].

This review focuses on the quest to understand AS at the molecular and cell biological levels. In addition to results from mouse model- and cell-based functional studies, recent insights into ALMS1 gene regulation and the interaction network of the encoded protein are highlighted.

The ALMS1 protein

ALMS1 is a large (> 4000 residue) protein that lacks known catalytic domains [11, 12]. It has several sequence features of unknown function, including a large tandem repeat domain (TRD), three short predicted coiled-coil domains and a stretch of ~ 130 residues at the C-terminus dubbed the ALMS motif (Fig. 3). The ALMS motif is the only region that shares obvious sequence similarity with other human proteins. It was defined on the basis of similarity to mammalian orthologues of C10orf90/FATS (fragile site-associated tumour suppressor) [11], reportedly an E2-independent ubiquitin ligase which stabilises p53 in response to DNA damage [83] and may localise to the centrosome and actin cytoskeleton [21]. A more divergent ALMS motif was subsequently identified at the C-terminus of CEP295/KIAA1731 [21], a large protein implicated in centriole assembly and maintenance [21, 84, 85, 86, 87]. Notably, the CEP295 ALMS motif appears to bind MTs [84]. Deletion analysis of ALMS1 suggests that its ALMS motif may contribute to centrosome-targeting [21]. However, the motif is not essential for centrosomal localisation of either ALMS1 or CEP295 [21, 84, 85].
Fig. 3

Sequence features of ALMS1. a Representation of the primary structure showing recognised features in relation to exon boundaries. The N-terminal polyglutamate (PolyE) tract is polymorphic [12] and is followed by seven alanine residues. Short lengths of the polyE tract have been associated with an increased risk of early-onset myocardial infarction in the general population [184]. CC predicted coiled-coil domain, LZ leucine zipper motif, pNLS potential nuclear localisation signal. Numbers below each feature refer to amino acid positions [11, 12, 21]. b Consensus sequence of the tandem repeat. The repeats are relatively rich in serine and proline residues and have little secondary structure-forming potential. Consensus generated using WebLogo [185], based on an alignment with seven gaps removed to facilitate display

Orthologues of ALMS1 are readily detectable in chordates, although most of the N-terminal half of the protein, which mainly comprises the TRD, appears to be specific to mammals [21; unpublished observation]. The proteomes of many ciliated eukaryotes, including unicellular organisms such as Tetrahymena and Paramecium, contain predicted proteins with C-terminal ALMS motif-like sequences, suggesting that the motif has an ancient, conserved function relating to centrioles or cilia [21].

Experimentally defined sites of post-translational modification in ALMS1 include a cluster of ubiquitination sites around the third predicted coiled-coil domain [88] and a DNA damage-regulated phosphorylation site (S2781) [89] (data accessed via PhosphoSitePlus [90]). Regarding the latter, it is notable that a genome-wide RNAi screen identified ALMS1 as one of ~ 800 genes required for resistance to ionising radiation in U2OS cells [91]. Other ciliopathy-associated proteins have been linked to DDR signalling [92] but the potential role of ALMS1 in this process remains to be investigated.

Regulation of ALMS1 gene expression

ALMS1 is widely expressed [11, 12, 19, 93] but its level of expression is context-dependent. For example, Alms1 mRNA declines during in vitro differentiation of 3T3-L1 preadipocytes [79, 94], possibly related to the observation that mature adipocytes lack primary cilia [95]. Conversely, it increases during terminal differentiation of neonatal mouse cardiomyocytes [15] and in cell culture conditions that promote cell cycle exit and primary cilium formation (i.e. serum-starvation or confluency) [57, 96, 97]. It also increases during differentiation of MCCs in vitro [98, 99], possibly reflecting a requirement for the protein at the hundreds of basal bodies assembled in these cells.

The ALMS1 promoter contains an evolutionarily conserved consensus binding site for ciliogenic RFX (regulatory factor X) transcription factors, three of which (RFX1, RFX2 and RFX3) have been implicated in activating ALMS1 transcription in response to serum-starvation [96]. Involvement of RFX proteins is supported by ChIP-Seq data from other studies, for example for murine Rfx1 and Rfx3 in neural progenitors and Min6 insulinoma cells, respectively [100, 101] (data accessed via the Cistrome Data Browser [102]). Vertebrate RFX2 and RFX3 have well-established roles in regulating ciliary genes in various tissues [103], while RFX1 has recently been reported to stimulate transcription of key ciliogenic genes downstream of leptin in hypothalamic neurons and to regulate other ciliary genes [104, 105]. However, it should be noted that RFX1 and RFX3 also regulate non-ciliary genes [100, 103, 106].

In Xenopus differentiating MCCs, Alms1 transcription appears to be upregulated by a protein complex containing Multicilin and the DNA-binding transcription factor E2f4 [99]. Many of the genes targeted by this complex in MCCs encode factors that, in proliferating cells, are known to be involved in centriole biogenesis [99].

Protein-protein interactions and proximity interactions

Numerous candidate ALMS1-interacting proteins have been reported. Members of the α-actinin family of actin-binding proteins were identified in yeast two-hybrid (Y2H) screens using the C-terminal region of murine Alms1 as bait, and co-immunoprecipitation data supported an interaction with α-actinin-4 (Actn4) in mouse kidney [76]. ACTN4 and another protein identified in the same Y2H screen (myosin Vb) are components of the cytoskeleton-associated recycling or transport (CART) complex, involved in endosomal recycling [107]. Myo5b also interacts with a key regulator of ‘slow’ recycling pathways, Rab11 [108], and shares the ability of Myo5a to interact with the ciliopathy protein RPGRIP1L [109]. α-Actinins and another protein identified in the same Y2H screen, Rab-interacting lysosomal protein-like 1 (Rilpl1), have also been implicated in ciliary roles [110, 111].

An ongoing human interactome study based on affinity purification coupled with mass spectrometry (AP-MS) [112, 113] has identified 18 potential ALMS1 interactors including the BBSome subunit BBS7; AVIL (advillin), which severs actin filaments and influences ciliogenesis [114]; RABL2A, the mouse orthologue of which binds CEP19 and IFT proteins [115, 116, 117]; cell division cycle 16 (CDC16), a component of the anaphase-promoting complex; dynamin 3 (DNM3), involved in membrane fission [118]; TFDP3, a dimerization partner of E2F transcription factors [119]; and dysbindin/dystrobrevin binding protein 1 (DTNBP1), a subunit of the BLOC-1 complex that is involved in recycling endosome formation and GPCR trafficking in the lysosomal pathway, and is required for trafficking of polycystin-2 to cilia [120, 121, 122]. Another global AP-MS study identified an interaction with VCIP135/valosin-containing protein-interacting protein 1 (VCPIP1) [123], a deubiquitinating enzyme which functions in membrane fusion [124, 125].

Other AP-MS studies have identified ALMS1 as a possible binding partner of the RNA polymerase II (RNAPII) subunit RPB1 [77]; the serine-arginine protein kinase SRPK2 [126]; GPCR-associated sorting protein 2 (GPRASP2), implicated in ciliary translocation of Smoothened, a key component of the Hh signalling pathway [127, 128]; and CEP192, a protein involved in centrosome biogenesis [129]. Consistent with the latter finding, ALMS1 was labelled by a CEP192-biotin ligase fusion (bait) in a proximity-dependent biotinylation (BioID) study [130]. However, because ALMS1 was labelled by baits representing several centriole duplication factors (PLK4, CEP152, CPAP, CEP63 and KIAA0753), it was suggested that at least in some cases this may reflect a dispersed localisation or high mobility within the centrosome [130]. In a BioID study focusing on centrioles, cilia and centriolar satellites, centriole assembly factors including CEP152, CPAP, CEP135 and SASS6 were among 11 baits producing high confidence proximity interactions with ALMS1 [131]. Collectively, these data may indicate that ALMS1 is present at the proximal ends of nascent procentrioles. However, the timing of ALMS1’s recruitment to newly forming centrioles is unknown, and it remains to be determined if the BioID results reflect physical interactions.

BioID has also identified ALMS1 as a potential interactor/substrate of the E3 ubiquitin ligase SCFβ-TrCP1 [132], and of separase [133], a protease that mediates separation of sister chromatids, and of newborn centrioles from their parents, in mitosis [134]. Another recent BioID study suggests links to proteins involved in the Hippo signalling pathway (LATS2 and AMOT; [135]). An updated list of reported physical and proximity interactions is available online at [136].

ALMS1 function

Cilium formation/maintenance

The notion that ALMS1 has a ciliary role probably first arose when BBS was linked to basal body/primary cilium dysfunction [137]. As outlined below, supporting evidence has emerged from analyses of ALMS1-deficient mice and ALMS1-depleted cultured cells, although not to date from analyses of AS patient fibroblasts.

Alms1GT/GT mice

Mice with a gene trap in intron 13 (Alms1GT/GT mice) appear to form cilia normally, based on electron microscopy analysis of renal collecting ducts, photoreceptors and airway epithelium [93]. However, within photoreceptors a fraction of rhodopsin mislocalises to the outer nuclear layer (ONL) and vesicles accumulate in the IS, suggesting a defect in the tethering, docking or fusion of rhodopsin carrier vesicles at the base of the connecting cilium [93] (Fig. 4a). Photoreceptor degeneration is evident by the age of 24 weeks in these mice.
Fig. 4

Selected cellular phenotypes observed in mouse models of AS. a Large membrane-bound vesicles accumulate in the inner segment (IS) of adult Alms1GT/GT rod photoreceptors. Immunofluorescence data indicate shortening of the inner and outer and segments (OS) at 24 weeks of age and mislocalisation of rhodopsin at 7 and 24 weeks of age [93]. Similar mislocalisation of rhodopsin occurs in Alms1L2131X/L2131X retina [57]. It is not known if mislocalised rhodopsin is vesicle-associated. b In neonatal Alms1GT/GT mice, some outer hair cells (OHC) in the organ of Corti display misoriented and/or misshapen bundles of stereocilia (actin-based structures) and mislocalisation of kinocilia (a type of primary cilium), indicating impaired cilium-dependent planar cell polarity. Inner hair cell (IHC) bundles appear unaffected [56]. c Representation of kidney proximal tubule epithelium in six month-old WT and Alms1L2131X/L2131X mice, based on data indicating tubule dilation and loss of primary cilia coupled with increased proliferation (Ki67 staining) and apoptosis (TUNEL staining) in the mutant [57]. d Loss of hypothalamic neuronal primary cilia occurs by 3 weeks of age in Alms1foz/foz mice [58]

In the developing organ of Corti in Alms1GT/GT mice, the kinocilium of outer hair cells (OHC) is often mis-positioned and some stereociliary bundles display defects in shape and orientation [56] (Fig. 4b). These abnormalities, which resemble those seen in mouse models of BBS [138], implicate ALMS1 in cilium-dependent PCP signalling [56]. The kinocilium appears to be required for normal bundle shape and orientation in individual OHCs, but not for polarisation of core PCP proteins [38]. Only ~ 20% of OHC bundles are affected in Alms1GT/GT mice, suggesting that Alms1 dysfunction renders this cell type susceptible to a stochastic event during development [56]. Progressive loss of OHCs also occurs and appears to be the main cause of hearing loss in these mice, although it is unclear if this is directly related to the observed bundle abnormalities [56].

Alms1L2131X/L2131X mice

Mice with an N-ethyl-N-nitrosourea (ENU)-induced nonsense mutation in exon 10 (Alms1L2131X/L2131X mice) exhibit loss of renal primary cilia by 6 months of age [57]. Notably, only certain proximal tubules are affected, suggesting that an additional, somatic, event may be required [57]. Cilia-loss correlates with increased proliferation and apoptosis of tubule epithelial cells [57] but whether it triggers these changes remains unknown (Fig. 4c). Rhodopsin mislocalises to the ONL in some photoreceptors of Alms1L2131X/L2131X mice, similar to Alms1GT/GT mice. Also of note, sperm flagella, which are structurally similar to cilia, are reduced in number and length compared to wild-type [57].

Alms1foz/foz mice

Mice with a truncating mutation in exon 8 (Alms1foz/foz mice) have also been reported to exhibit age-dependent loss of primary cilia, in this case on hypothalamic neurons [58]. The loss begins between 5 days and 3 weeks of age, based on staining for AC3 (adenylate cyclase type 3), and seems to occur rapidly because the remaining cilia are not significantly shorter than those of control mice (Fig. 4d). Loss of cilia was supported by staining for three additional ciliary proteins (Sstr3, Mchr1 and Arl13b). Because the markers used are not core structural components of cilia, it is formally possible that their trafficking to cilia is blocked in subsets of Alms1foz/foz neurons. However, on the reasonable assumption that cilia are lost, the detection of Sstr3 and Mhcr1 in remaining cilia [58] is notable because ciliary localisation of these GPCRs is abrogated in Bbs and tubby mutant mice [71, 139].

Hypothalamic neuronal primary cilia are implicated in regulating satiety responses (via factors including Mchr1 and AC3) [139, 140, 141] and Alms1foz/foz mice are reportedly hyperphagic before becoming obese [82]. Thus, resorption or degeneration of these cilia may contribute to the development of obesity in these mice [58]. Although Alms1GT/GT and Alms1L2131X/L2131X mice also become obese [57, 93], preceding hyperphagia has not been documented and it is not known if loss of hypothalamic primary cilia occurs. Another notable feature of Alms1foz/foz mice is the degeneration of germ cells during spermatogenesis, particularly at the round-to-elongating stage during which flagella assembly occurs, although the assembly process is completed in some cells [82].

In summary, the initial formation of primary cilia appears normal in all three mouse models reported to date, consistent with their lack of obvious developmental phenotypes. However, age-dependent loss of primary cilia has been observed in Alms1L2131X/L2131X and Alms1foz/foz mice. Cilia-related deficits in a third model (Alms1GT/GT mice) include mislocalisation of rhodopsin and mispositioning of OHC kinocilia. Whether differences in the occurrence/timing of cilia-loss seen in these studies reflect the nature of the mutations, the focus on different cell types, or other factors, remains uncertain.

AS patient fibroblasts and ALMS1 siRNA-treated cells

The formation of primary cilia seems to be unaffected in AS patient fibroblasts in vitro [19, 76, 142]. Hh and PDGFA signalling, both of which act through the cilium, also appear to be normal [142]. In stark contrast, transient RNAi-mediated depletion of ALMS1 has been reported to cause severe defects in ciliary structure. Ball-like staining of the ciliary axoneme marker acetylated tubulin was apparent in Alms1-depleted mouse inner medullary collecting duct (IMCD3) cells, using two different siRNAs [57]. These malformed cilia were also functionally defective, based on measurement of intracellular calcium in response to fluid flow. A cDNA construct encoding the N-terminal 40% of Alms1 was reported to rescue cilium formation, although the effect was not quantified and the subcellular localisation of this N-terminal fragment was not reported [57]. Knockdown of ALMS1 in human telomerase-immortalised retinal pigmented epithelium (hTERT-RPE1) cells has similarly been reported to result in the appearance of morphologically abnormal, stunted cilia [59], although whether the two siRNAs tested produced exactly the same effect is unclear.

Notably, Alms1 immunofluorescence is clearly visible at centrosomes in Alms1L2131X/L2131X and Alms1GT/GT mice, but not Alms1-depleted IMCD3 cells, using an N-terminal antibody [56, 57]. Moreover, Alms1 siRNA treatment has been reported to inhibit ciliogenesis in Alms1L2131X/L2131X embryonic fibroblasts [57]. These findings suggest that RNAi suppresses ALMS1 expression more comprehensively than truncating mutations, at least in murine cells, offering a possible explanation for the striking effects on cilium morphology [57]. If this is the case, then true null mutations in ALMS1 would likely disrupt ciliogenesis (assuming lack of adaptive compensation), leading to severe developmental defects and possibly embryonic lethality.

On the other hand, it could be argued that additional data are needed to confirm that the catastrophic ciliary defects seen in siRNA-treated cells are due to depletion of ALMS1. It is notable that Alms1 immunostaining was not detected in Alms1foz/foz neurons [58], nor in fibroblasts from 14 out of 16 AS patients with biallelic nonsense/frameshift mutations [142], implying the absence of residual protein function. Nevertheless, expression of ALMS1 isoforms lacking the antibody epitopes used for detection cannot be excluded in these cases.

Maintenance of centrosome cohesion and composition

The specific localisation of ALMS1 to the proximal ends of centrioles [21] is unusual for a ciliopathy-associated protein. Filaments emanating from this zone make up the centrosome linker, a structure that helps to maintain the close pairing of mother and daughter centrioles, termed centrosome cohesion ([143, 144]; Fig. 2). RNAi data have implicated ALMS1 in the proximal end-recruitment of CEP250/C-Nap1 [21], a protein that anchors the centrosome linker and a related structure called the ciliary rootlet (Figs. 2 and 5a) [143, 144, 145]. Consistently, centrosome cohesion appears to be compromised in ALMS1-depleted cells ([21]; Fig. 5a).
Fig. 5

Potential involvement of ALMS1 in centrosome cohesion and endosomal trafficking. a ALMS1 has been implicated in anchoring the centrosome cohesion protein C-Nap1/CEP250 to centriole proximal ends [21], akin to CEP135 [186, 161]. Loss of CEP250 from these sites in ALMS1-depleted cells is accompanied by centrosome splitting [21]. The CEP250-associated kinase NEK2 is also lost, but not from the distal portion of the mother centriole (MC) [162]. The effect shown here on rootletin-containing fibres is inferred based on the rootletin-anchoring function of CEP250 [143, 144]. DC daughter centriole. b Endosomal trafficking of Notch and TfR (transferrin receptor) appears to be altered in ALMS1-deficient cells. Notch accumulates in late endosomes (LE) in ALMS1-depleted cells, potentially leading to increased signalling [74]. Clearance of Tf is delayed in fibroblasts derived from AS patients, suggesting impaired TfR recycling. Reported physical interactions between ALMS1 and CART complex components led to the suggestion that fast recycling of TfR may be impaired [76], indicated here by dashed arrows/question marks. EE early endosome, RE recycling endosome

There is some evidence that mutations in human CEP250 lead to retinal dystrophy and SNHL [146, 147, 148], and CEP250 is known to interact with proteins implicated in rhodopsin trafficking (NEK2 and NINL) [149, 150, 151, 152]. It is also worth noting that human Tubby and the core PCP protein Dvl2 localise to the rootlet [153, 154]. CEP250 does not seem to be required for primary cilium formation or maintenance [59, 155, 156, 157], although a recent conflicting report suggests that ciliogenesis cannot proceed if centrosome cohesion is lost [158]. Another recent study showed that CEP250 contributes to retaining the cilium in a submerged state, affecting its capacity to sense external cues [159]. CEP250 appears to be crucial for the recruitment of several proteins to centriole proximal ends, including Girdin (Girders of actin filaments) and a group of proteins that associate also with the distal region of the mother centriole (NEK2, ninein, CEP170, p150glued and KIF2A) [159, 160, 161, 162]. Thus, recruitment of these proteins to centriole proximal ends may depend indirectly on ALMS1, and there is evidence of this in the case of NEK2 ([162]; Fig. 5a).

In addition to CEP250 and NEK2, centrosomal levels of the PCM protein PCNT are modestly reduced in ALMS1-depleted hTERT-RPE1 cells [21]. Like ALMS1, PCNT has been implicated in ciliogenesis, maintenance of centrosome cohesion and adipogenesis [31, 163, 164]. Moreover, PCNT mutations lead to severe insulin resistance, dyslipidemia and diabetes in the context of microcephalic osteodysplastic primordial dwarfism type 2 (MOPDII) [31]. Centrosomal recruitment of PCNT is mediated in part by polyglutamate chains added post-translationally to centriolar tubulin [165], making it tempting to speculate that the N-terminal polyglutamate tract of ALMS1 could act in a similar fashion.

It is not hard to imagine ALMS1 performing a structural role such as tethering other proteins to the base of centrioles. Alternatively, it could influence centrosome composition indirectly. Recent data indicate that pericentrosomal levels of centriolar satellites, key regulators of centrosome composition, are enhanced in ALMS1-depleted cells [131]. However, it should be emphasised that the above findings are based on RNAi and await confirmation by rescue experiments and genetic studies.

Actin cytoskeleton organisation

Immunofluorescence analysis of filamentous actin in AS patient fibroblasts revealed the presence of non-uniform and stunted filaments, in addition to stress fibres similar to those of control cells [76]. A separate electron microscopy-based analysis of AS fibroblasts revealed abnormal orientation of microfilaments (a.k.a. actin filaments) [75]. Also of note, these cells displayed a reduced ability to migrate in 3D culture, strong anchoring of cytoplasmic extensions, increased production of extracellular matrix (ECM), an extended cell cycle and resistance to chemically induced apoptosis [75]. It is not known how ALMS1 dysfunction leads to defects in F-actin organisation, although, as noted above, physical interactions with actin-binding/regulatory proteins have been reported [76, 113]. It remains to be investigated if ALMS1 is important for the recently discovered ability of centrosomes to nucleate actin filaments [25].

Endosomal trafficking of transferrin and Notch

Impairments in the trafficking and recycling of endocytosed transferrin (Tf) have been noted in AS patient fibroblasts [76]. The transferrin receptor showed enhanced accumulation in the pericentrosomal region, while uptake of labelled transferrin was slightly impaired and its exit from the recycling compartment delayed compared to control fibroblasts. The positioning of the pericentrosomal endosomal recycling compartment, marked by Rab11, was unaffected. In the same study, an antibody raised to a C-terminal peptide of murine Alms1 was found to stain the contractile ring and cleavage furrow (sites to which the endosomal recycling machinery is recruited) as well as cytoplasmic ACTN1-immunopositive dense bodies, but not centrosomes, in Madin-Darby canine kidney (MDCK) cells. Based on these and additional data mentioned above, it was speculated that ALMS1 may be required for the cytoskeletal architecture that enables endosomal recycling, and/or function together with the CART complex to facilitate rapid endosome transport along actin filaments ([76]; Fig. 5b).

Endosomal trafficking of Notch, a receptor involved in multiple processes including cell fate determination during development, also appears to be disrupted in ALMS1-deficient cells, although in this case the recycling branch of the pathway was not significantly affected [74]. Specifically, Notch was reported to accumulate in late endosomes in ALMS1-depleted hTERT-RPE1 cells and a slight (1.2-fold) but statistically significant increase in expression of the Notch target gene HES5 was detected in ALMS1-depleted HEK293 cells (Fig. 5b). Overactivation of Notch signalling could have wide-ranging impacts relevant to the pathogenesis of AS including extending the proliferative window of neonatal cardiomyocytes and exacerbating selective insulin resistance in the liver [166, 167]. Notch signalling has been reported to utilise the primary cilium [168]; however, ALMS1 does not appear to be required for localisation of NOTCH1 to the basal body or cilium [74]. Of note, depletion of BBS proteins similarly leads to accumulation of Notch in late endosomes but also impairs endocytic recycling and basal body/ciliary localisation of the receptor [74].

GLUT4 trafficking and/or adipogenesis

Indications that ALMS1 influences endocytic recycling suggested that it could have a role in glucose transporter type 4 (GLUT4) trafficking [76]. Insulin-stimulated movement of GLUT4 from intracellular stores to the plasma membrane in fat and muscle cells plays a key role in maintaining whole-body glucose homeostasis [169]. Analysis of adipose tissue from Alms1GT/GT mice revealed that the level of GLUT4 in the plasma membrane fraction was higher in the basal than the insulin-stimulated state, and that the overall level of GLUT4 was reduced compared to control [73]. Moreover, Alms1GT/GT preadipocytes differentiated in vitro showed reduced insulin-stimulated GLUT4 translocation and glucose uptake compared to wild type cells [73]. Phosphorylation of Akt, the main insulin-regulated signal transducer for GLUT4 translocation, appeared to be unaffected in Alms1GT/GT adipose tissue, suggesting that ALMS1 functions either downstream or independently of Akt [73]. The actin cytoskeletal defects observed in patient fibroblasts and the reported physical interaction between Alms1 and Actn4 [76] may provide clues to the underlying mechanism [73, 170]. However, as outlined below, there are conflicting data regarding the importance of Alms1 for insulin-stimulated glucose uptake (and, by implication, GLUT4 trafficking).

Earlier RNAi experiments using 3T3-L1 preadipocytes indicated that Alms1 is important for adipogenic differentiation [79], whereas preadipocytes from Alms1GT/GT mice showed no such differentiation defect in vitro [73]. This discrepancy may reflect cell line specificity or a difference in the level of residual Alms1 function present, as suggested to explain the ability of patient fibroblasts and Alms1 mutant mice to assemble morphologically normal primary cilia [57]. Of note here, signalling pathways with positive (IGF-1R) and negative (Wnt and Hh) effects on adipogenesis utilise cilia [45, 95, 171], but whether ALMS1 deficiency affects ciliation during this process is not known.

Similar to the later analysis of Alms1GT/GT mouse adipose tissue, Alms1 did not appear to be required for proximal insulin signalling in 3T3-L1 adipocytes [79]. However, neither did it seem to be required for insulin-stimulated glucose uptake, since the modest decreases observed in Alms1-depleted 3T3-L1 adipocytes could be accounted for by impaired differentiation [79]. This study suggests an alternative mechanism contributing to insulin resistance in AS. Namely, that a partial defect in adipogenesis would reduce the ability of adipose tissue to expand in situations of caloric excess, leading to the development of insulin resistance at other sites [79, 172]. However, since the severity of insulin resistance in AS often exceeds that in congenital generalised lipodystrophy, other factors are likely involved [79].


As noted earlier, ALMS1 has been identified as a potential binding partner of the RNAPII subunit RPB1 [77]. In the same study, punctate nuclear (and cytoplasmic) anti-ALMS1 staining was observed with two different antibodies in cryosections of HeLa cells and murine tissues, and immunolabeling of ALMS1 was found to block subsequent immunolabeling of RPB1, suggesting colocalisation (based on antibody steric hindrance). Supporting the biological relevance of these findings, ALMS1 knockdown reduced global transcription levels in HeLa cells. Thus, these data suggest that ALMS1 localises to the nucleus and is important for sustaining the transcriptional activity of RNAPII [77]. Deficiency of ALMS1 has been associated with altered gene expression profiles in other systems [75, 173, 174]; however, it is unclear if these effects are direct. Of note, the transcriptional program associated with ciliogenesis/confluency was unaffected in Alms1-depleted IMCD3 cells [57], suggesting that impaired transcription is unlikely to underlie the severe ciliary defects observed in these cells.


Perhaps not surprisingly given the complexity of the AS phenotype, ALMS1 appears to have multiple functions. The photoreceptor phenotype of Alms1GT/GT mice hints at involvement in the transition from vesicular to intraciliary transport, a process controlled in part by the small GTPase Rab8 and in which ciliopathy proteins including CC2D2A and BBS proteins have been implicated [61, 151, 175, 176]. Other studies suggest that ALMS1-deficiency leads to a wider impairment of vesicular transport, affecting Notch signalling, GLUT4-mediated glucose uptake and potentially many other processes. It remains unclear if the underlying cause of these transport deficits is disruption of the actin cytoskeleton (as observed in AS patient fibroblasts), of MTs or of specific trafficking steps. Following up on leads from protein-protein interaction data, recently significantly enriched by a human interactome study [113], may help to clarify this. Notably, perturbation of either the actin cytoskeleton or the endocytic recycling pathway can affect ciliogenesis and cilium length [114]. However, as discussed earlier, the importance of ALMS1 for cilium structure remains somewhat uncertain, due in part to the lack of obvious ciliary defects in patient-derived fibroblasts.

The application of proximity labelling has raised the intriguing possibility that ALMS1 interacts with centriole assembly factors, similarly to the ALMS motif-containing protein CEP295/KIAA1731. Although centriole-loss has not been observed in ALMS1-deficient cells, a subtler defect, which could affect both ciliary and extraciliary functions of the centrosome, remains a possibility. Loss of the centrosome cohesion protein CEP250/C-Nap1 from ALMS1-depleted centrioles could be a manifestation of such a defect. Indications that ALMS1 has roles in transcription [77] and possibly the DDR [89, 91] suggest additional areas for further research.

Immunofluorescence data placing ALMS1 at locations such as the nucleus and cleavage furrow support the idea that multiple isoforms of the protein exist. However, it is important to note that these localisation data have yet to be confirmed by, for example, parallel analysis of ALMS1-depleted cells. Further work is needed to explore the range of ALMS1 transcripts produced by cells, their functional capacities and potential relevance to phenotypic variability in AS.

It remains plausible that primary cilium or basal body dysfunction contributes to many aspects of the AS phenotype including obesity, retinal dystrophy, hearing-loss, kidney dysfunction, neurological disturbances and fibrosis [48, 52, 78]. Moreover, data implicating pancreatic β cell primary cilia in the regulation of insulin secretion [177] raise the possibility that a ciliary defect contributes to the progressive failure of insulin secretion that occurs in AS and is the major factor in progression to diabetes [178]. Dysfunction of motile cilia could contribute to other clinical aspects of AS including respiratory problems, chronic otitis media in childhood and abnormal spinal curvature in adolescence [179, 180]. Although evidence that ALMS1-deficiency directly impacts motile cilia is lacking at present, upregulation of ALMS1 expression during MCC differentiation is intriguing.

Whether a ciliary defect could impair cardiomyocyte cell cycle arrest, leading to infantile DCM/mitogenic cardiomyopathy, is uncertain. Signalling pathways linked to primary cilia in other contexts (e.g. Hippo, Wnt, IGF-1R, Notch) are among the many factors thought to regulate this arrest [167, 181]. However, mammalian cardiomyocytes appear to lose the ability to assemble a primary cilium shortly after birth, concomitant with loss of centrosome integrity and redistribution of centrosomal proteins to the nuclear periphery [182].

Clearly, much remains to be learned about this giant protein. The identification of bona fide interacting partners remains an important goal, as does, more straightforwardly, confirmation of extra-centrosomal sites of localisation. Structural data may reveal homologies not detectable at the sequence level, helping to reveal the functions of individual domains. The establishment of zebrafish models of AS [80, 173] will facilitate in vivo functional studies, the identification of genetic interactions and therapeutic testing/screening. However, the relatively poor evolutionary conservation of ALMS1 is a limitation of non-mammalian models. Gene editing and the generation of patient-derived induced pluripotent stem cells are likely to play important roles in resolving the functions of the human protein. While this article was in production, it was reported that Alms1 physically interacts with and promotes endocytosis of the renal Na-K-Cl cotransporter NKCC2 in the thick ascending limb (TAL) of the loop of Henle [187]. Alms1 knockout rats developed hypertension (a feature observed in 30% of AS patients [4]), suggested to be due at least in part to NKCC2 accumulation at the apical cell surface and higher TAL NaCl transport. Kidney tubule primary cilia were reported to be of normal length.



I would like to thank the individuals with Alstrӧm syndrome, and their families, for supporting and participating in research.

Compliance with ethical standards

Human tissue was obtained with local research ethics committee permission and written informed consent.

Conflict of interest

The author declares that there is no conflict of interest.


  1. 1.
    Alström CH, Hallgren B, Nilsson LB, Asander H (1959) Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand 34:1–35Google Scholar
  2. 2.
    Marshall JD, Maffei P, Collin GB, Naggert JK (2011) Alstrom syndrome: genetics and clinical overview. Curr Genomics 12:225–235Google Scholar
  3. 3.
    Marshall JD, Beck S, Maffei P, Naggert JK (2007) Alstrom Syndrome. Eur J Hum Genet 15:1193–1202Google Scholar
  4. 4.
    Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM (2005) New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165:675–683Google Scholar
  5. 5.
    Boerwinkle C, Marshall JD, Bryant J, Gahl WA, Olivier KN, Gunay-Aygun M (2016) Respiratory manifestations in 38 patients with Alstrom syndrome. Pediatr Pulmonol 52:487–493Google Scholar
  6. 6.
    Ozanturk A, Marshall JD, Collin GB, Duzenli S, Marshall RP, Candan S, Tos T, Esen I, Taskesen M, Cayir A, Ozturk S, Ustun I, Ataman E, Karaca E, Ozdemir TR, Erol I, Eroglu FK, Torun D, Pariltay E, Yilmaz-Gulec E, Atabek ME, Elcioglu N, Satman I, Moller C, Muller J, Naggert JK, Ozgul RK (2015) The phenotypic and molecular genetic spectrum of Alstrom syndrome in 44 Turkish kindreds and a literature review of Alstrom syndrome in Turkey. J Hum Genet 60:1–9Google Scholar
  7. 7.
    Brofferio A, Sachdev V, Hannoush H, Marshall JD, Naggert JK, Sidenko S, Noreuil A, Sirajuddin A, Bryant J, Han JC, Arai AE, Gahl WA, Gunay-Aygun M (2017) Characteristics of cardiomyopathy in Alstrom syndrome: prospective single-center data on 38 patients. Mol Genet Metab 121:336–343Google Scholar
  8. 8.
    O'Rahilly S (2009) Human genetics illuminates the paths to metabolic disease. Nature 462:307–314Google Scholar
  9. 9.
    Girard D, Petrovsky N (2011) Alstrom syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol 7:77–88Google Scholar
  10. 10.
    Orphanet (2018) The portal for rare diseases and orphan drugs. Accessed 16 Oct 2018
  11. 11.
    Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin M, Nishina PM, Naggert JK (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 31:74–78Google Scholar
  12. 12.
    Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, White C, Connolly V, Taylor JF, Russell-Eggitt I, Bonneau D, Walker M, Wilson DI (2002) Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet 31:79–83Google Scholar
  13. 13.
    Astuti D, Sabir A, Fulton P, Zatyka M, Williams D, Hardy C, Milan G, Favaretto F, Yu-Wai-Man P, Rohayem J, de Heredia ML, Hershey T, Tranebjaerg L, Chen JH, Chaussenot A, Nunes V, Marshall B, McAfferty S, Tillmann V, Maffei P, Paquis-Flucklinger V, Geberhiwot T, Mlynarski W, Parkinson K, Picard V, Bueno GE, Dias R, Arnold A, Richens C, Paisey R, Urano F, Semple R, Sinnott R, Barrett TG (2017) Monogenic diabetes syndromes: locus-specific databases for Alstrom, Wolfram and Thiamine-responsive megaloblastic anaemia. Hum Mutat 38:764–777Google Scholar
  14. 14.
    Marshall JD, Muller J, Collin GB, Milan G, Kingsmore SF, Dinwiddie D, Farrow EG, Miller NA, Favaretto F, Maffei P, Dollfus H, Vettor R, Naggert JK (2015) Alstrom syndrome: mutation spectrum of ALMS1. Hum Mutat 36:660–668Google Scholar
  15. 15.
    Shenje LT, Andersen P, Halushka MK, Lui C, Fernandez L, Collin GB, Amat-Alarcon N, Meschino W, Cutz E, Chang K, Yonescu R, Batista DA, Chen Y, Chelko S, Crosson JE, Scheel J, Vricella L, Craig BD, Marosy BA, Mohr DW, Hetrick KN, Romm JM, Scott AF, Valle D, Naggert JK, Kwon C, Doheny KF, Judge DP (2014) Mutations in Alstrom protein impair terminal differentiation of cardiomyocytes. Nat Commun 5:3416Google Scholar
  16. 16.
    Louw JJ, Corveleyn A, Jia Y, Iqbal S, Boshoff D, Gewillig M, Peeters H, Moerman P, Devriendt K (2014) Homozygous loss-of-function mutation in ALMS1 causes the lethal disorder mitogenic cardiomyopathy in two siblings. Eur J Med Genet 57:532–535Google Scholar
  17. 17.
    Foglia MJ, Poss KD (2016) Building and re-building the heart by cardiomyocyte proliferation. Development 143:729–740Google Scholar
  18. 18.
    Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M (2003) Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426:570–574Google Scholar
  19. 19.
    Hearn T, Spalluto C, Phillips VJ, Renforth GL, Copin N, Hanley NA, Wilson DI (2005) Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 54:1581–1587Google Scholar
  20. 20.
    Nigg EA, Holland AJ (2018) Once and only once: mechanisms of centriole duplication and their deregulation in disease. Nat Rev Mol Cell Biol 19:297–312Google Scholar
  21. 21.
    Knorz VJ, Spalluto C, Lessard M, Purvis TL, Adigun FF, Collin GB, Hanley NA, Wilson DI, Hearn T (2010) Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731. Mol Biol Cell 21:3617–3629Google Scholar
  22. 22.
    Welte MA (2014) Bidirectional transport along microtubules. Curr Biol 14:R525–R537Google Scholar
  23. 23.
    Nigg EA, Raff JW (2009) Centrioles, centrosomes, and cilia in health and disease. Cell 139:663–678Google Scholar
  24. 24.
    Hehnly H, Chen C-T, Powers Christine M, Liu H-L, Doxsey S (2012) The centrosome regulates the Rab11-dependent recycling endosome pathway at appendages of the mother centriole. Curr Biol 22:1944–1950Google Scholar
  25. 25.
    Farina F, Gaillard J, Guerin C, Coute Y, Sillibourne J, Blanchoin L, Thery M (2016) The centrosome is an actin-organizing centre. Nat Cell Biol 18:65–75Google Scholar
  26. 26.
    Stinchcombe JC, Griffiths GM (2014) Communication, the centrosome and the immunological synapse. Philos Trans R Soc Lond Ser B Biol Sci 369:20130463Google Scholar
  27. 27.
    Vora SM, Phillips BT (2016) The benefits of local depletion: the centrosome as a scaffold for ubiquitin-proteasome-mediated degradation. Cell Cycle 15:2124–2134Google Scholar
  28. 28.
    Mullee LI, Morrison CG (2016) Centrosomes in the DNA damage response - the hub outside the centre. Chromosom Res 24:35–51Google Scholar
  29. 29.
    Arquint C, Gabryjonczyk A-M, Nigg EA (2014) Centrosomes as signalling centres. Philos Trans R Soc Lond Ser B Biol Sci 369:20130464Google Scholar
  30. 30.
    Chen JH, Segni M, Payne F, Huang-Doran I, Sleigh A, Adams C, Savage DB, O'Rahilly S, Semple RK, Barroso I (2015) Truncation of POC1A associated with short stature and extreme insulin resistance. J Mol Endocrinol 55:147–158Google Scholar
  31. 31.
    Huang-Doran I, Bicknell LS, Finucane FM, Rocha N, Porter KM, YCL T, Szekeres F, Krook A, Nolan JJ, O’Driscoll M, Bober M, O’Rahilly S, Jackson AP, Semple RK (2011) Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes. Diabetes 60:925–935Google Scholar
  32. 32.
    Shalata A, Ramirez MC, Desnick RJ, Priedigkeit N, Buettner C, Lindtner C, Mahroum M, Abdul-Ghani M, Dong F, Arar N, Camacho-Vanegas O, Zhang R, Camacho SC, Chen Y, Ibdah M, DeFronzo R, Gillespie V, Kelley K, Dynlacht BD, Kim S, Glucksman MJ, Borochowitz ZU, Martignetti JA (2013) Morbid obesity resulting from inactivation of the ciliary protein CEP19 in humans and mice. Am J Hum Genet 93:1061–1071Google Scholar
  33. 33.
    Ishikawa H, Marshall WF (2011) Ciliogenesis: building the cell's antenna. Nat Rev Mol Cell Biol 12:222–234Google Scholar
  34. 34.
    Benmerah A (2014) The ciliary pocket. Curr Opin Cell Biol 25:78–84Google Scholar
  35. 35.
    Garcia-Gonzalo FR, Reiter JF (2017) Open sesame: how transition fibers and the transition zone control ciliary composition. Cold Spring Harb Perspect Biol 9:a028134Google Scholar
  36. 36.
    Molday RS, Moritz OL (2015) Photoreceptors at a glance. J Cell Sci 128:4039–4045Google Scholar
  37. 37.
    Schwander M, Kachar B, Muller U (2010) The cell biology of hearing. J Cell Biol 190:9–20Google Scholar
  38. 38.
    Jones C, Roper VC, Foucher I, Qian D, Banizs B, Petit C, Yoder BK, Chen P (2008) Ciliary proteins link basal body polarization to planar cell polarity regulation. Nat Genet 40:69–77Google Scholar
  39. 39.
    Fry AM, Leaper MJ, Bayliss R (2014) The primary cilium: guardian of organ development and homeostasis. Organogenesis 10:62–68Google Scholar
  40. 40.
    Mariman EC, Vink RG, Roumans NJ, Bouwman FG, Stumpel CT, Aller EE, van Baak MA, Wang P (2016) The cilium: a cellular antenna with an influence on obesity risk. Br J Nutr 116:576–592Google Scholar
  41. 41.
    Oh EC, Vasanth S, Katsanis N (2015) Metabolic regulation and energy homeostasis through the primary cilium. Cell Metab 21:21–31Google Scholar
  42. 42.
    Bangs F, Anderson KV (2017) Primary cilia and mammalian hedgehog signaling. Cold Spring Harb Perspect Biol 9:a028175Google Scholar
  43. 43.
    Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P, Christensen ST (2005) PDGFRαα signaling is regulated through the primary cilium in fibroblasts. Curr Biol 15:1861–1866Google Scholar
  44. 44.
    Yeh C, Li A, Chuang J-Z, Saito M, Cáceres A, Sung C-H (2013) IGF-1 activates a cilium-localized noncanonical Gβγ signaling pathway that regulates cell-cycle progression. Dev Cell 26:358–368Google Scholar
  45. 45.
    Zhu D, Shi S, Wang H, Liao K (2009) Growth arrest induces primary-cilium formation and sensitizes IGF-1-receptor signaling during differentiation induction of 3T3-L1 preadipocytes. J Cell Sci 122:2760–2768Google Scholar
  46. 46.
    Christensen ST, Morthorst SK, Mogensen JB, Pedersen LB (2017) Primary cilia and coordination of receptor tyrosine kinase (RTK) and transforming growth factor beta (TGF-beta) signaling. Cold Spring Harb Perspect Biol 9:a028167Google Scholar
  47. 47.
    Hilgendorf KI, Johnson CT, Jackson PK (2016) The primary cilium as a cellular receiver: organizing ciliary GPCR signaling. Curr Opin Cell Biol 39:84–92Google Scholar
  48. 48.
    Seeger-Nukpezah T, Golemis EA (2012) The extracellular matrix and ciliary signaling. Curr Opin Cell Biol 24:652–661Google Scholar
  49. 49.
    Spasic M, Jacobs CR (2017) Primary cilia: cell and molecular mechanosensors directing whole tissue function. Semin Cell Dev Biol 71:42–52Google Scholar
  50. 50.
    Delling M, Indzhykulian AA, Liu X, Li Y, Xie T, Corey DP, Clapham DE (2016) Primary cilia are not calcium-responsive mechanosensors. Nature 531:656–660Google Scholar
  51. 51.
    Malicki JJ, Johnson CA (2016) The cilium: cellular antenna and central processing unit. Trends Cell Biol 27:126–140Google Scholar
  52. 52.
    Reiter JF, Leroux MR (2017) Genes and molecular pathways underpinning ciliopathies. Nat Rev Mol Cell Biol 18:533–547Google Scholar
  53. 53.
    Braun DA, Hildebrandt F (2017) Ciliopathies. Cold Spring Harb Perspect Biol 9:a028191Google Scholar
  54. 54.
    Mitchison HM, Valente EM (2017) Motile and non-motile cilia in human pathology: from function to phenotypes. J Pathol 241:294–309Google Scholar
  55. 55.
    Novarino G, Akizu N, Gleeson JG (2011) Modeling human disease in humans: the ciliopathies. Cell 147:70–79Google Scholar
  56. 56.
    Jagger D, Collin G, Kelly J, Towers E, Nevill G, Longo-Guess C, Benson J, Halsey K, Dolan D, Marshall J, Naggert J, Forge A (2010) Alstrom syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity. Hum Mol Genet 20:466–481Google Scholar
  57. 57.
    Li G, Vega R, Nelms K, Gekakis N, Goodnow C, McNamara P, Wu H, Hong NA, Glynne R (2007) A role for Alstrom syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet 3:e8Google Scholar
  58. 58.
    Heydet D, Chen LX, Larter CZ, Inglis C, Silverman MA, Farrell GC, Leroux MR (2013) A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice. Dev Neurobiol 73:1–13Google Scholar
  59. 59.
    Graser S, Stierhof YD, Lavoie SB, Gassner OS, Lamla S, Le Clech M, Nigg EA (2007) Cep164, a novel centriole appendage protein required for primary cilium formation. J Cell Biol 179:321–330Google Scholar
  60. 60.
    Pereiro I, Hoskins BE, Marshall JD, Collin GB, Naggert JK, Pineiro-Gallego T, Oitmaa E, Katsanis N, Valverde D, Beales PL (2011) Arrayed primer extension technology simplifies mutation detection in Bardet-Biedl and Alstrom syndrome. Eur J Hum Genet 19:485–488Google Scholar
  61. 61.
    Nachury MV, Loktev AV, Zhang Q, Westlake CJ, Peranen J, Merdes A, Slusarski DC, Scheller RH, Bazan JF, Sheffield VC, Jackson PK (2007) A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 129:1201–1213Google Scholar
  62. 62.
    Seo S, Baye LM, Schulz NP, Beck JS, Zhang Q, Slusarski DC, Sheffield VC (2010) BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. Proc Natl Acad Sci U S A 107:1488–1493Google Scholar
  63. 63.
    Wei Q, Zhang Y, Li Y, Zhang Q, Ling K, Hu J (2012) The BBSome controls IFT assembly and turnaround in cilia. Nat Cell Biol 14:950–957Google Scholar
  64. 64.
    Lechtreck KF, Johnson EC, Sakai T, Cochran D, Ballif BA, Rush J, Pazour GJ, Ikebe M, Witman GB (2009) The Chlamydomonas reinhardtii BBSome is an IFT cargo required for export of specific signaling proteins from flagella. J Cell Biol 187:1117–1132Google Scholar
  65. 65.
    Jin H, White SR, Shida T, Schulz S, Aguiar M, Gygi SP, Bazan JF, Nachury MV (2010) The conserved Bardet-Biedl syndrome proteins assemble a coat that traffics membrane proteins to cilia. Cell 141:1208–1219Google Scholar
  66. 66.
    Starks RD, Beyer AM, Guo DF, Boland L, Zhang Q, Sheffield VC, Rahmouni K (2015) Regulation of insulin receptor trafficking by Bardet Biedl syndrome proteins. PLoS Genet 11:e1005311Google Scholar
  67. 67.
    Guo D-F, Cui H, Zhang Q, Morgan DA, Thedens DR, Nishimura D, Grobe JL, Sheffield VC, Rahmouni K (2016) The BBSome controls energy homeostasis by mediating the transport of the leptin receptor to the plasma membrane. PLoS Genet 12:e1005890Google Scholar
  68. 68.
    Kleyn PW, Fan W, Kovats SG, Lee JJ, Pulido JC, Wu Y, Berkemeier LR, Misumi DJ, Holmgren L, Charlat O, Woolf EA, Tayber O, Brody T, Shu P, Hawkins F, Kennedy B, Baldini L, Ebeling C, Alperin GD, Deeds J, Lakey ND, Culpepper J, Chen H, Glucksmann-Kuis MA, Carlson GA, Duyk GM, Moore KJ (1996) Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 85:281–290Google Scholar
  69. 69.
    Noben-Trauth K, Naggert JK, North MA, Nishina PM (1996) A candidate gene for the mouse mutation tubby. Nature 380:534–538Google Scholar
  70. 70.
    Park J, Lee J, Shim J, Han W, Lee J, Bae YC, Chung YD, Kim CH, Moon SJ (2013) dTULP, the Drosophila melanogaster homolog of tubby, regulates transient receptor potential channel localization in cilia. PLoS Genet 9:e1003814Google Scholar
  71. 71.
    Sun X, Haley J, Bulgakov O, Cai X, McGinnis J, Li T (2012) Tubby is required for trafficking G protein-coupled receptors to neuronal cilia. Cilia 1:21Google Scholar
  72. 72.
    Santagata S, Boggon TJ, Baird CL, Gomez CA, Zhao J, Shan WS, Myszka DG, Shapiro L (2001) G-protein signaling through tubby proteins. Science 292:2041–2050Google Scholar
  73. 73.
    Favaretto F, Milan G, Collin GB, Marshall JD, Stasi F, Maffei P, Vettor R, Naggert JK (2014) GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance. PLoS One 9:e109540Google Scholar
  74. 74.
    Leitch CC, Lodh S, Prieto-Echague V, Badano JL, Zaghloul NA (2014) Basal body proteins regulate notch signaling through endosomal trafficking. J Cell Sci 127:2407–2419Google Scholar
  75. 75.
    Zulato E, Favaretto F, Veronese C, Campanaro S, Marshall JD, Romano S, Cabrelle A, Collin GB, Zavan B, Belloni AS, Rampazzo E, Naggert JK, Abatangelo G, Sicolo N, Maffei P, Milan G, Vettor R (2011) ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS One 6:e19081Google Scholar
  76. 76.
    Collin GB, Marshall JD, King BL, Milan G, Maffei P, Jagger DJ, Naggert JK (2012) The Alstrom syndrome protein, ALMS1, interacts with alpha-actinin and components of the endosome recycling pathway. PLoS One 7:e37925Google Scholar
  77. 77.
    Moller A, Xie SQ, Hosp F, Lang B, Phatnani HP, James S, Ramirez F, Collin GB, Naggert JK, Babu MM, Greenleaf AL, Selbach M, Pombo A (2012) Proteomic analysis of mitotic RNA polymerase II reveals novel interactors and association with proteins dysfunctional in disease. Mol Cell Proteomics 11:M111.011767Google Scholar
  78. 78.
    Guo J, Higginbotham H, Li J, Nichols J, Hirt J, Ghukasyan V, Anton ES (2015) Developmental disruptions underlying brain abnormalities in ciliopathies. Nat Commun 6:7857Google Scholar
  79. 79.
    Huang-Doran I, Semple RK (2010) Knockdown of the Alstrom syndrome-associated gene Alms1 in 3T3-L1 preadipocytes impairs adipogenesis but has no effect on cell-autonomous insulin action. Int J Obes 34:1554–1558Google Scholar
  80. 80.
    Lodh S, Hostelley TL, Leitch CC, O'Hare EA, Zaghloul NA (2016) Differential effects on beta-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes. Hum Mol Genet 25:57–68Google Scholar
  81. 81.
    Poekes L, Legry V, Schakman O, Detrembleur C, Bol A, Horsmans Y, Farrell GC, Leclercq IA (2017) Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice. Clin Sci 131:285–296Google Scholar
  82. 82.
    Arsov T, Silva DG, O’Bryan MK, Sainsbury A, Lee NJ, Kennedy C, Manji SS, Nelms K, Liu C, Vinuesa CG, de Kretser DM, Goodnow CC, Petrovsky N (2006) Fat Aussie - a new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol 20:1610–1622Google Scholar
  83. 83.
    Yan S, Qiu L, Ma K, Zhang X, Zhao Y, Zhang J, Li X, Hao X, Li Z (2014) FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage. Oncogene 33:5424–5433Google Scholar
  84. 84.
    Chang CW, Hsu WB, Tsai JJ, Tang CC, Tang TK (2016) CEP295 interacts with microtubules and is required for centriole elongation. J Cell Sci 129:2501–2513Google Scholar
  85. 85.
    Tsuchiya Y, Yoshiba S, Gupta A, Watanabe K, Kitagawa D (2016) Cep295 is a conserved scaffold protein required for generation of a bona fide mother centriole. Nat Commun 7:12567Google Scholar
  86. 86.
    Izquierdo D, Wang WJ, Uryu K, Tsou MF (2014) Stabilization of cartwheel-less centrioles for duplication requires CEP295-mediated centriole-to-centrosome conversion. Cell Rep 8:957–965Google Scholar
  87. 87.
    Fu J, Lipinszki Z, Rangone H, Min M, Mykura C, Chao-Chu J, Schneider S, Dzhindzhev NS, Gottardo M, Riparbelli MG, Callaini G, Glover DM (2016) Conserved molecular interactions in centriole-to-centrosome conversion. Nat Cell Biol 18:87–99Google Scholar
  88. 88.
    Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10:634–637Google Scholar
  89. 89.
    Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160–1166Google Scholar
  90. 90.
    Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E (2015) PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res 43:D512–D520Google Scholar
  91. 91.
    Hurov KE, Cotta-Ramusino C, Elledge SJ (2010) A genetic screen identifies the triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev 24:1939–1950Google Scholar
  92. 92.
    Chaki M, Airik R, Ghosh AK, Giles RH, Chen R, Slaats GG, Wang H, Hurd TW, Zhou W, Cluckey A, Gee HY, Ramaswami G, Hong CJ, Hamilton BA, Cervenka I, Ganji RS, Bryja V, Arts HH, van Reeuwijk J, Oud MM, Letteboer SJ, Roepman R, Husson H, Ibraghimov-Beskrovnaya O, Yasunaga T, Walz G, Eley L, Sayer JA, Schermer B, Liebau MC, Benzing T, Le Corre S, Drummond I, Janssen S, Allen SJ, Natarajan S, O'Toole JF, Attanasio M, Saunier S, Antignac C, Koenekoop RK, Ren H, Lopez I, Nayir A, Stoetzel C, Dollfus H, Massoudi R, Gleeson JG, Andreoli SP, Doherty DG, Lindstrad A, Golzio C, Katsanis N, Pape L, Abboud EB, Al-Rajhi AA, Lewis RA, Omran H, Lee EY, Wang S, Sekiguchi JM, Saunders R, Johnson CA, Garner E, Vanselow K, Andersen JS, Shlomai J, Nurnberg G, Nurnberg P, Levy S, Smogorzewska A, Otto EA, Hildebrandt F (2012) Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell 150:533–548Google Scholar
  93. 93.
    Collin GB, Cyr E, Bronson R, Marshall JD, Gifford EJ, Hicks W, Murray SA, Zheng QY, Smith RS, Nishina PM, Naggert JK (2005) Alms1-disrupted mice recapitulate human Alstrom syndrome. Hum Mol Genet 14:2323–2333Google Scholar
  94. 94.
    Romano S, Milan G, Veronese C, Collin GB, Marshall JD, Centobene C, Favaretto F, Dal Pra C, Scarda A, Leandri S, Naggert JK, Maffei P, Vettor R (2008) Regulation of Alstrom syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity. Int J Mol Med 21:731–736Google Scholar
  95. 95.
    Marion V, Stoetzel C, Schlicht D, Messaddeq N, Koch M, Flori E, Danse JM, Mandel JL, Dollfus H (2009) Transient ciliogenesis involving Bardet-Biedl syndrome proteins is a fundamental characteristic of adipogenic differentiation. Proc Natl Acad Sci U S A 106:1820–1825Google Scholar
  96. 96.
    Purvis TL, Hearn T, Spalluto C, Knorz VJ, Hanley KP, Sanchez-Elsner T, Hanley NA, Wilson DI (2010) Transcriptional regulation of the Alström syndrome gene ALMS1 by members of the RFX family and Sp1. Gene 460:20–29Google Scholar
  97. 97.
    Yabuta N, Onda H, Watanabe M, Yoshioka N, Nagamori I, Funatsu T, Toji S, Tamai K, Nojima H (2006) Isolation and characterization of the TIGA genes, whose transcripts are induced by growth arrest. Nucleic Acids Res 34:4878–4892Google Scholar
  98. 98.
    Hoh RA, Stowe TR, Turk E, Stearns T (2012) Transcriptional program of ciliated epithelial cells reveals new cilium and centrosome components and links to human disease. PLoS One 7:e52166Google Scholar
  99. 99.
    Ma L, Quigley I, Omran H, Kintner C (2014) Multicilin drives centriole biogenesis via E2f proteins. Genes Dev 28:1461–1471Google Scholar
  100. 100.
    Elkon R, Milon B, Morrison L, Shah M, Vijayakumar S, Racherla M, Leitch CC, Silipino L, Hadi S, Weiss-Gayet M, Barras E, Schmid CD, Ait-Lounis A, Barnes A, Song Y, Eisenman DJ, Eliyahu E, Frolenkov GI, Strome SE, Durand B, Zaghloul NA, Jones SM, Reith W, Hertzano R (2015) RFX transcription factors are essential for hearing in mice. Nat Commun 6:8549Google Scholar
  101. 101.
    Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107:21931–21936Google Scholar
  102. 102.
    Mei S, Qin Q, Wu Q, Sun H, Zheng R, Zang C, Zhu M, Wu J, Shi X, Taing L, Liu T, Brown M, Meyer CA, Liu XS (2017) Cistrome data browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse. Nucleic Acids Res 45:D658–D662Google Scholar
  103. 103.
    Choksi SP, Lauter G, Swoboda P, Roy S (2014) Switching on cilia: transcriptional networks regulating ciliogenesis. Development 141:1427–1441Google Scholar
  104. 104.
    Kang GM, Han YM, Ko HW, Kim J, Oh BC, Kwon I, Kim M-S (2015) Leptin elongates hypothalamic neuronal cilia via transcriptional regulation and actin destabilization. J Biol Chem 290:18146–18155Google Scholar
  105. 105.
    Tammimies K, Bieder A, Lauter G, Sugiaman-Trapman D, Torchet R, Hokkanen M-E, Burghoorn J, Castren E, Kere J, Tapia-Paez I, Swoboda P (2016) Ciliary dyslexia candidate genes DYX1C1 and DCDC2 are regulated by regulatory factor (RF) X transcription factors through X-box promoter motifs. FASEB J 30:3578–3587Google Scholar
  106. 106.
    Thomas J, Morlé L, Soulavie F, Laurençon A, Sagnol S, Durand B (2010) Transcriptional control of genes involved in ciliogenesis: a first step in making cilia. Biol Cell 102:499–513Google Scholar
  107. 107.
    Yan Q, Sun W, Kujala P, Lotfi Y, Vida TA, Bean AJ (2005) CART: an Hrs/actinin-4/BERP/myosin V protein complex required for efficient receptor recycling. Mol Biol Cell 16:2470–2482Google Scholar
  108. 108.
    Lapierre LA, Kumar R, Hales CM, Navarre J, Bhartur SG, Burnette JO, Provance DW, Mercer JA, Bahler M, Goldenring JR (2001) Myosin Vb is associated with plasma membrane recycling systems. Mol Biol Cell 12:1843–1857Google Scholar
  109. 109.
    Assis LH, Silva-Junior RM, Dolce LG, Alborghetti MR, Honorato RV, Nascimento AF, Melo-Hanchuk TD, Trindade DM, Tonoli CC, Santos CT, Oliveira PS, Larson RE, Kobarg J, Espreafico EM, Giuseppe PO, Murakami MT (2017) The molecular motor myosin Va interacts with the cilia-centrosomal protein RPGRIP1L. Sci Rep 7:43692Google Scholar
  110. 110.
    Schaub JR, Stearns T (2013) The Rilp-like proteins Rilpl1 and Rilpl2 regulate ciliary membrane content. Mol Biol Cell 24:453–464Google Scholar
  111. 111.
    Kohli P, Hohne M, Jungst C, Bertsch S, Ebert LK, Schauss AC, Benzing T, Rinschen MM, Schermer B (2017) The ciliary membrane-associated proteome reveals actin-binding proteins as key components of cilia. EMBO Rep 18:1521–1535Google Scholar
  112. 112.
    Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, Tam S, Zarraga G, Colby G, Baltier K, Dong R, Guarani V, Vaites LP, Ordureau A, Rad R, Erickson BK, Wuhr M, Chick J, Zhai B, Kolippakkam D, Mintseris J, Obar RA, Harris T, Artavanis-Tsakonas S, Sowa ME, De Camilli P, Paulo JA, Harper JW, Gygi SP (2015) The BioPlex network: a systematic exploration of the human Interactome. Cell 162:425–440Google Scholar
  113. 113.
    Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW (2017) Architecture of the human interactome defines protein communities and disease networks. Nature 545:505–509Google Scholar
  114. 114.
    Kim J, Lee JE, Heynen-Genel S, Suyama E, Ono K, Lee K, Ideker T, Aza-Blanc P, Gleeson JG (2010) Functional genomic screen for modulators of ciliogenesis and cilium length. Nature 464:1048–1051Google Scholar
  115. 115.
    Lo JCY, Jamsai D, O’Connor AE, Borg C, Clark BJ, Whisstock JC, Field MC, Adams V, Ishikawa T, Aitken RJ, Whittle B, Goodnow CC, Ormandy CJ, O’Bryan MK (2012) RAB-like 2 has an essential role in male fertility, sperm intra-flagellar transport, and tail assembly. PLoS Genet 8:e1002969Google Scholar
  116. 116.
    Kanie T, Abbott KL, Mooney NA, Plowey ED, Demeter J, Jackson PK (2017) The CEP19-RABL2 GTPase complex binds IFT-B to initiate intraflagellar transport at the ciliary base. Dev Cell 42:22–36Google Scholar
  117. 117.
    Nishijima Y, Hagiya Y, Kubo T, Takei R, Katoh Y, Nakayama K (2017) RABL2 interacts with the IFT-B complex and CEP19, and participates in ciliary assembly. Mol Biol Cell 28:1652–1666Google Scholar
  118. 118.
    Antonny B, Burd C, De Camilli P, Chen E, Daumke O, Faelber K, Ford M, Frolov VA, Frost A, Hinshaw JE, Kirchhausen T, Kozlov MM, Lenz M, Low HH, McMahon H, Merrifield C, Pollard TD, Robinson PJ, Roux A, Schmid S (2016) Membrane fission by dynamin: what we know and what we need to know. EMBO J 35:2270–2284Google Scholar
  119. 119.
    Milton A, Luoto K, Ingram L, Munro S, Logan N, Graham AL, Brummelkamp TR, Hijmans EM, Bernards R, La Thangue NB (2006) A functionally distinct member of the DP family of E2F subunits. Oncogene 25:3212Google Scholar
  120. 120.
    Delevoye C, Heiligenstein X, Ripoll L, Gilles-Marsens F, Dennis MK, Linares RA, Derman L, Gokhale A, Morel E, Faundez V, Marks MS, Raposo G (2016) BLOC-1 brings together the actin and microtubule cytoskeletons to generate recycling endosomes. Curr Biol 26:1–13Google Scholar
  121. 121.
    Marley A, von Zastrow M (2010) Dysbindin promotes the post-endocytic sorting of G protein-coupled receptors to lysosomes. PLoS One 5:e9325Google Scholar
  122. 122.
    Monis WJ, Faundez V, Pazour GJ (2017) BLOC-1 is required for selective membrane protein trafficking from endosomes to primary cilia. J Cell Biol 216:2131–2150Google Scholar
  123. 123.
    Hein MY, Hubner NC, Poser I, Cox J, Nagaraj N, Toyoda Y, Gak IA, Weisswange I, Mansfeld J, Buchholz F, Hyman AA, Mann M (2015) A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 163:712–723Google Scholar
  124. 124.
    Wang Y, Satoh A, Warren G, Meyer HH (2004) VCIP135 acts as a deubiquitinating enzyme during p97-p47-mediated reassembly of mitotic Golgi fragments. J Cell Biol 164:973–978Google Scholar
  125. 125.
    Uchiyama K, Jokitalo E, Kano F, Murata M, Zhang X, Canas B, Newman R, Rabouille C, Pappin D, Freemont P, Kondo H (2002) VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J Cell Biol 159:855–866Google Scholar
  126. 126.
    Varjosalo M, Keskitalo S, Van Drogen A, Nurkkala H, Vichalkovski A, Aebersold R, Gstaiger M (2013) The protein interaction landscape of the human CMGC kinase group. Cell Rep 3:1306–1320Google Scholar
  127. 127.
    Jung B, Padula D, Burtscher I, Landerer C, Lutter D, Theis F, Messias AC, Geerlof A, Sattler M, Kremmer E, Boldt K, Ueffing M, Lickert H (2016) Pitchfork and Gprasp2 target smoothened to the primary cilium for hedgehog pathway activation. PLoS One 11:e0149477Google Scholar
  128. 128.
    Li S, Wang L, Fu B, Berman MA, Diallo A, Dorf ME (2014) TRIM65 regulates microRNA activity by ubiquitination of TNRC6. Proc Natl Acad Sci U S A 111:6970–6975Google Scholar
  129. 129.
    Gomez-Ferreria MA, Bashkurov M, Mullin M, Gingras A-C, Pelletier L (2012) CEP192 interacts physically and functionally with the K63-deubiquitinase CYLD to promote mitotic spindle assembly. Cell Cycle 11:3555–3558Google Scholar
  130. 130.
    Firat-Karalar EN, Rauniyar N, Yates JR 3rd, Stearns T (2014) Proximity interactions among centrosome components identify regulators of centriole duplication. Curr Biol 24:664–670Google Scholar
  131. 131.
    Gupta GD, Coyaud E, Goncalves J, Mojarad BA, Liu Y, Wu Q, Gheiratmand L, Comartin D, Tkach JM, Cheung SW, Bashkurov M, Hasegan M, Knight JD, Lin ZY, Schueler M, Hildebrandt F, Moffat J, Gingras AC, Raught B, Pelletier L (2015) A dynamic protein interaction landscape of the human centrosome-cilium interface. Cell 163:1484–1499Google Scholar
  132. 132.
    Coyaud E, Mis M, Laurent EMN, Dunham WH, Couzens AL, Robitaille M, Gingras A-C, Angers S, Raught B (2015) BioID-based identification of Skp Cullin F-box (SCF)beta-TrCP1/2 E3 ligase substrates. Mol Cell Proteomics 14:1781–1795Google Scholar
  133. 133.
    Agircan FG, Hata S, Nussbaum-Krammer C, Atorino E, Schiebel E (2016) Proximity mapping of human separase by the BioID approach. Biochem Biophys Res Commun 478:656–662Google Scholar
  134. 134.
    Tsou MF, Stearns T (2006) Mechanism limiting centrosome duplication to once per cell cycle. Nature 442:947–951Google Scholar
  135. 135.
    Couzens AL, Knight JDR, Kean MJ, Teo G, Weiss A, Dunham WH, Lin Z-Y, Bagshaw RD, Sicheri F, Pawson T, Wrana JL, Choi H, Gingras A-C (2013) Protein interaction network of the mammalian hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci Signal 6:rs15-rs15Google Scholar
  136. 136.
    Chatr-aryamontri A, Oughtred R, Boucher L, Rust J, Chang C, Kolas NK, O'Donnell L, Oster S, Theesfeld C, Sellam A, Stark C, Breitkreutz B-J, Dolinski K, Tyers M (2017) The BioGRID interaction database: 2017 update. Nucleic Acids Res 45:D369–D379Google Scholar
  137. 137.
    Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskins BE, Leitch CC, Kim JC, Ross AJ, Eichers ER, Teslovich TM, Mah AK, Johnsen RC, Cavender JC, Lewis RA, Leroux MR, Beales PL, Katsanis N (2003) Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425:628–633Google Scholar
  138. 138.
    Ross AJ, May-Simera H, Eichers ER, Kai M, Hill J, Jagger DJ, Leitch CC, Chapple JP, Munro PM, Fisher S, Tan PL, Phillips HM, Leroux MR, Henderson DJ, Murdoch JN, Copp AJ, Eliot MM, Lupski JR, Kemp DT, Dollfus H, Tada M, Katsanis N, Forge A, Beales PL (2005) Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat Genet 37:1135–1140Google Scholar
  139. 139.
    Berbari NF, Lewis JS, Bishop GA, Askwith CC, Mykytyn K (2008) Bardet-Biedl syndrome proteins are required for the localization of G protein-coupled receptors to primary cilia. Proc Natl Acad Sci U S A 105:4242–4246Google Scholar
  140. 140.
    Wang Z, Li V, Chan GC, Phan T, Nudelman AS, Xia Z, Storm DR (2009) Adult type 3 adenylyl cyclase-deficient mice are obese. PLoS One 4:e6979Google Scholar
  141. 141.
    Davenport JR, Watts AJ, Roper VC, Croyle MJ, van Groen T, Wyss JM, Nagy TR, Kesterson RA, Yoder BK (2007) Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr Biol 17:1586–1594Google Scholar
  142. 142.
    Chen JH, Geberhiwot T, Barrett TG, Paisey R, Semple RK (2017) Refining genotype-phenotype correlation in Alstrom syndrome through study of primary human fibroblasts. Mol Genet Genomic Med 5:390–404Google Scholar
  143. 143.
    Bahe S, Stierhof YD, Wilkinson CJ, Leiss F, Nigg EA (2005) Rootletin forms centriole-associated filaments and functions in centrosome cohesion. J Cell Biol 171:27–33Google Scholar
  144. 144.
    Yang J, Adamian M, Li T (2006) Rootletin interacts with C-Nap1 and may function as a physical linker between the pair of centrioles/basal bodies in cells. Mol Biol Cell 17:1033–1040Google Scholar
  145. 145.
    Mayor T, Stierhof YD, Tanaka K, Fry AM, Nigg EA (2000) The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. J Cell Biol 151:837–846Google Scholar
  146. 146.
    Khateb S, Zelinger L, Mizrahi-Meissonnier L, Ayuso C, Koenekoop RK, Laxer U, Gross M, Banin E, Sharon D (2014) A homozygous nonsense CEP250 mutation combined with a heterozygous nonsense C2orf71 mutation is associated with atypical Usher syndrome. J Med Genet 51:460–469Google Scholar
  147. 147.
    de Castro-Miro M, Tonda R, Escudero-Ferruz P, Andres R, Mayor-Lorenzo A, Castro J, Ciccioli M, Hidalgo DA, Rodriguez-Ezcurra JJ, Farrando J, Perez-Santonja JJ, Cormand B, Marfany G, Gonzalez-Duarte R (2016) Novel candidate genes and a wide spectrum of structural and point mutations responsible for inherited retinal dystrophies revealed by exome sequencing. PLoS One 11:e0168966Google Scholar
  148. 148.
    Kubota D, Gocho K, Kikuchi S, Akeo K, Miura M, Yamaki K, Takahashi H, Kameya S (2018) CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family. Ophthalmic Genet 39:500–507Google Scholar
  149. 149.
    Fogeron ML, Muller H, Schade S, Dreher F, Lehmann V, Kuhnel A, Scholz AK, Kashofer K, Zerck A, Fauler B, Lurz R, Herwig R, Zatloukal K, Lehrach H, Gobom J, Nordhoff E, Lange BM (2013) LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat Commun 4:1531Google Scholar
  150. 150.
    Fry AM, Mayor T, Meraldi P, Stierhof YD, Tanaka K, Nigg EA (1998) C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2. J Cell Biol 141:1563–1574Google Scholar
  151. 151.
    Bachmann-Gagescu R, Dona M, Hetterschijt L, Tonnaer E, Peters T, de Vrieze E, Mans DA, van Beersum SEC, Phelps IG, Arts HH, Keunen JE, Ueffing M, Roepman R, Boldt K, Doherty D, Moens CB, Neuhauss SCF, Kremer H, van Wijk E (2015) The ciliopathy protein CC2D2A associates with NINL and functions in RAB8-MICAL3-regulated vesicle trafficking. PLoS Genet 11:e1005575Google Scholar
  152. 152.
    Nishiguchi KM, Tearle RG, Liu YP, Oh EC, Miyake N, Benaglio P, Harper S, Koskiniemi-Kuendig H, Venturini G, Sharon D, Koenekoop RK, Nakamura M, Kondo M, Ueno S, Yasuma TR, Beckmann JS, Ikegawa S, Matsumoto N, Terasaki H, Berson EL, Katsanis N, Rivolta C (2013) Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene. Proc Natl Acad Sci U S A 110:16139–16144Google Scholar
  153. 153.
    Borman AD, Pearce LR, Mackay DS, Nagel-Wolfrum K, Davidson AE, Henderson R, Garg S, Waseem NH, Webster AR, Plagnol V, Wolfrum U, Farooqi IS, Moore AT (2014) A homozygous mutation in the TUB gene associated with retinal dystrophy and obesity. Hum Mutat 35:289–293Google Scholar
  154. 154.
    Park TJ, Mitchell BJ, Abitua PB, Kintner C, Wallingford JB (2008) Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nat Genet 40:871–879Google Scholar
  155. 155.
    Panic M, Hata S, Neuner A, Schiebel E (2015) The centrosomal linker and microtubules provide dual levels of spatial coordination of centrosomes. PLoS Genet 11:e1005243Google Scholar
  156. 156.
    Floriot S, Vesque C, Rodriguez S, Bourgain-Guglielmetti F, Karaiskou A, Gautier M, Duchesne A, Barbey S, Fritz S, Vasilescu A, Bertaud M, Moudjou M, Halliez S, Cormier-Daire V, J ELH, Nigg EA, Manciaux L, Guatteo R, Cesbron N, Toutirais G, Eggen A, Schneider-Maunoury S, Boichard D, Sobczak-Thepot J, Schibler L (2015) C-Nap1 mutation affects centriole cohesion and is associated with a Seckel-like syndrome in cattle. Nat Commun 6:6894Google Scholar
  157. 157.
    Flanagan AM, Stavenschi E, Basavaraju S, Gaboriau D, Hoey DA, Morrison CG (2017) Centriole splitting caused by loss of the centrosomal linker protein C-NAP1 reduces centriolar satellite density and impedes centrosome amplification. Mol Biol Cell 28:736–745Google Scholar
  158. 158.
    Loukil A, Tormanen K, Sutterlin C (2017) The daughter centriole controls ciliogenesis by regulating Neurl-4 localization at the centrosome. J Cell Biol 216:1287–1300Google Scholar
  159. 159.
    Mazo G, Soplop N, Wang WJ, Uryu K, Tsou MB (2016) Spatial control of primary ciliogenesis by subdistal appendages alters sensation-associated properties of cilia. Dev Cell 39:424–437Google Scholar
  160. 160.
    Nechipurenko IV, Olivier-Mason A, Kazatskaya A, Kennedy J, McLachlan IG, Heiman MG, Blacque OE, Sengupta P (2016) A conserved role for Girdin in basal body positioning and ciliogenesis. Dev Cell 38:493–506Google Scholar
  161. 161.
    Hardy T, Lee M, Hames RS, Prosser SL, Cheary D-M, Samant MD, Schultz F, Baxter JE, Rhee K, Fry AM (2014) Multisite phosphorylation of C-Nap1 releases it from Cep135 to trigger centrosome disjunction. J Cell Sci 127:2493–2506Google Scholar
  162. 162.
    Spalluto C, Wilson DI, Hearn T (2012) Nek2 localises to the distal portion of the mother centriole/basal body and is required for timely cilium disassembly at the G2/M transition. Eur J Cell Biol 91:675–686Google Scholar
  163. 163.
    Jurczyk A, Gromley A, Redick S, San Agustin J, Witman G, Pazour GJ, Peters DJ, Doxsey S (2004) Pericentrin forms a complex with intraflagellar transport proteins and polycystin-2 and is required for primary cilia assembly. J Cell Biol 166:637–643Google Scholar
  164. 164.
    Graser S, Stierhof YD, Nigg EA (2007) Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesion. J Cell Sci 120:4321–4331Google Scholar
  165. 165.
    Madarampalli B, Yuan Y, Liu D, Lengel K, Xu Y, Li G, Yang J, Liu X, Lu Z, Liu DX (2015) ATF5 connects the pericentriolar materials to the proximal end of the mother centriole. Cell 162:580–592Google Scholar
  166. 166.
    Bi P, Kuang S (2015) Notch signaling as a novel regulator of metabolism. Trends Endocrinol Metab 26:248–255Google Scholar
  167. 167.
    Collesi C, Zentilin L, Sinagra G, Giacca M (2008) Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol 183:117–128Google Scholar
  168. 168.
    Ezratty EJ, Stokes N, Chai S, Shah AS, Williams SE, Fuchs E (2011) A role for the primary cilium in Notch signaling and epidermal differentiation during skin development. Cell 145:1129–1141Google Scholar
  169. 169.
    Leto D, Saltiel AR (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13:383–396Google Scholar
  170. 170.
    Talior-Volodarsky I, Randhawa VK, Zaid H, Klip A (2008) Alpha-actinin-4 is selectively required for insulin-induced GLUT4 translocation. J Biol Chem 283:25115–25123Google Scholar
  171. 171.
    Lowe CE, O'Rahilly S, Rochford JJ (2011) Adipogenesis at a glance. J Cell Sci 124:2681–2686Google Scholar
  172. 172.
    Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U (2015) Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab 26:193–200Google Scholar
  173. 173.
    Hostelley TL, Lodh S, Zaghloul NA (2016) Whole organism transcriptome analysis of zebrafish models of Bardet-Biedl syndrome and Alstrom syndrome provides mechanistic insight into shared and divergent phenotypes. BMC Genomics 17:318Google Scholar
  174. 174.
    Butler MG, Wang K, Marshall JD, Naggert JK, Rethmeyer JA, Gunewardena SS, Manzardo AM (2015) Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alstrom syndromes. Adv Genomics Genet 2015:53–75Google Scholar
  175. 175.
    Moritz OL, Tam BM, Hurd LL, Peranen J, Deretic D, Papermaster DS (2001) Mutant rab8 impairs docking and fusion of rhodopsin-bearing post-Golgi membranes and causes cell death of transgenic Xenopus rods. Mol Biol Cell 12:2341–2351Google Scholar
  176. 176.
    Wang J, Deretic D (2013) Molecular complexes that direct rhodopsin transport to primary cilia. Prog Retin Eye Res 38:1–19Google Scholar
  177. 177.
    Gerdes JM, Christou-Savina S, Xiong Y, Moede T, Moruzzi N, Karlsson-Edlund P, Leibiger B, Leibiger IB, Ostenson CG, Beales PL, Berggren PO (2014) Ciliary dysfunction impairs beta-cell insulin secretion and promotes development of type 2 diabetes in rodents. Nat Commun 5:5308Google Scholar
  178. 178.
    Bettini V, Maffei P, Pagano C, Romano S, Milan G, Favaretto F, Marshall JD, Paisey R, Scolari F, Greggio NA, Tosetto I, Naggert JK, Sicolo N, Vettor R (2012) The progression from obesity to type 2 diabetes in Alström syndrome. Pediatr Diabetes 13:59–67Google Scholar
  179. 179.
    Spassky N, Meunier A (2017) The development and functions of multiciliated epithelia. Nat Rev Mol Cell Biol 18:423–436Google Scholar
  180. 180.
    Grimes DT, Boswell CW, Morante NF, Henkelman RM, Burdine RD, Ciruna B (2016) Zebrafish models of idiopathic scoliosis link cerebrospinal fluid flow defects to spine curvature. Science 352:1341–1344Google Scholar
  181. 181.
    Xiao Y, Leach J, Wang J, Martin JF (2016) Hippo/yap signaling in cardiac development and regeneration. Curr Treat Options Cardiovasc Med 18(38)Google Scholar
  182. 182.
    Zebrowski DC, Vergarajauregui S, Wu C-C, Piatkowski T, Becker R, Leone M, Hirth S, Ricciardi F, Falk N, Giessl A, Just S, Braun T, Weidinger G, Engel FB (2015) Developmental alterations in centrosome integrity contribute to the post-mitotic state of mammalian cardiomyocytes. Elife 4:e05563Google Scholar
  183. 183.
    Seeley ES, Nachury MV (2010) The perennial organelle: assembly and disassembly of the primary cilium. J Cell Sci 123:511–518Google Scholar
  184. 184.
    Ichihara S, Yamamoto K, Asano H, Nakatochi M, Sukegawa M, Ichihara G, Izawa H, Hirashiki A, Takatsu F, Umeda H, Iwase M, Inagaki H, Hirayama H, Sone T, Nishigaki K, Minatoguchi S, Cho M-C, Jang Y, Kim H-S, Park JE, Tada-Oikawa S, Kitajima H, Matsubara T, Sunagawa K, Shimokawa H, Kimura A, Lee J-Y, Murohara T, Inoue I, Yokota M (2013) Identification of a glutamic acid repeat polymorphism of ALMS1 as a novel genetic risk marker for early-onset myocardial infarction by genome-wide linkage analysis. Circulation 6:569–578Google Scholar
  185. 185.
    Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14:1188–1190Google Scholar
  186. 186.
    Kim K, Lee S, Chang J, Rhee K (2008) A novel function of CEP135 as a platform protein of C-NAP1 for its centriolar localization. Exp Cell Res 314:3692–3700Google Scholar
  187. 187.
    Jaykumar AB, Caceres PS, King-Medina KN, Liao TD, Datta I, Maskey D, Naggert JK, Mendez M, Beierwaltes WH, Ortiz PA (2018) Role of Alström syndrome 1 in the regulation of blood pressure and renal function. JCI Insight 3:e95076Google Scholar

Copyright information

© The Author(s) 2018

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Institute of Life ScienceSwansea University Medical SchoolSwanseaUK

Personalised recommendations